Experimental melanoma vaccine shows promising results
An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients. It's personalized for each patient and optimized using artificial intelligence. Dr. Jon LaPook has more details.
We haven't written up this one. CBS News has the full story — the link below goes straight to it.